Vaccination Strategies against Highly Pathogenic Arenaviruses: The Next Steps toward Clinical Trials

The Safety of Yellow Fever Vaccine 17D or 17DD in Children, Pregnant Women, HIV+ Individuals, and Older Persons: Systematic Review

(2012) Roger E. Thomas et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Development of a new hydrogen peroxide–based vaccine platform

(2012) Ian J Amanna et al.   NATURE MEDICINE

Argentine hemorrhagic fever vaccines

(2011) Ana Ambrosio et al.   Human vaccines & immunotherapeutics

Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany

(2011) Stephan Günther et al.   JOURNAL OF INFECTIOUS DISEASES

Human CD8+ and CD4+ T Cell Memory to Lymphocytic Choriomeningitis Virus Infection

(2011) M. F. Kotturi et al.   JOURNAL OF VIROLOGY

Vaccination Alters the Balance between Protective Immunity, Exhaustion, Escape, and Death in Chronic Infections

(2011) P. L. F. Johnson et al.   JOURNAL OF VIROLOGY

The Major Determinant of Attenuation in Mice of the Candid1 Vaccine for Argentine Hemorrhagic Fever Is Located in the G2 Glycoprotein Transmembrane Domain

(2011) C. G. Albarino et al.   JOURNAL OF VIROLOGY

A Recombinant Influenza A Virus Expressing Domain III of West Nile Virus Induces Protective Immune Responses against Influenza and West Nile Virus

(2011) Byron E. E. Martina et al.   PLoS One

Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression

(2011) K. M. Hastie et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Multivalent Vaccination Strategy for the Prevention of Old World Arenavirus Infection in Humans

(2010) J. Botten et al.   JOURNAL OF VIROLOGY

Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity

(2010) Lukas Flatz et al.   NATURE MEDICINE

Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs

(2010) Xiaohong Jiang et al.   VACCINE

Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever

(2010) Luis M Branco et al.   Virology Journal

T Cell-Dependence of Lassa Fever Pathogenesis

(2010) Lukas Flatz et al.   PLoS Pathogens

Impact of Epitope Escape on PD-1 Expression and CD8 T-Cell Exhaustion during Chronic Infection

(2009) J. N. Blattman et al.   JOURNAL OF VIROLOGY

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

(2009) Bruno Guy et al.   VACCINE

A Multivalent and Cross-Protective Vaccine Strategy against Arenaviruses Associated with Human Disease

(2009) Maya F. Kotturi et al.   PLoS Pathogens

Phylogeny of the genus Arenavirus

(2008) Rémi N Charrel et al.   CURRENT OPINION IN MICROBIOLOGY

Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection againstLeishmania

(2008) Blaise Dondji et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Human Effector and Memory CD8+ T Cell Responses to Smallpox and Yellow Fever Vaccines

(2008) Joseph D. Miller et al.   IMMUNITY

Different Mechanisms of Cell Entry by Human-Pathogenic Old World and New World Arenaviruses

(2008) J. M. Rojek et al.   JOURNAL OF VIROLOGY

Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates

(2008) Igor S. Lukashevich et al.   VACCINE